PDF(228 KB)
加拿大高血压防控策略及措施
孙殿军, 赵亚双, 张微, 吕延杰, 田野, 张勇, 高彦辉, 李霞, 符金铭, 杨宝峰
中国工程科学 ›› 2017, Vol. 19 ›› Issue (2) : 117-121.
PDF(228 KB)
PDF(228 KB)
加拿大高血压防控策略及措施
Strategy and Measurement for Prevention and Control of Hypertension in Canada
高血压是世界公共健康的焦点问题之一。目前，加拿大是世界高血压防控效果最为显著的国家之一，在高血压防控策略、措施的制定和执行方面开展了广泛深入的研究。本文对加拿大高血压的流行、控制策略与措施情况（包括加拿大高血压协会和加拿大高血压教育计划、公共政策、社区干预、卫生保健系统）进行介绍，以便为我国制定高血压防控政策提供借鉴。
Hypertension is a public health issue around the world. At present, Canada is one of the few countries that have achieved remarkable success in the prevention and control of hypertension. Canada has accumulated a considerable amount of advanced experience in the control of hypertension and in the implementation of effective measures against it. This article introduces the prevalence of hypertension in Canada and the development of control strategies and measures against hypertension in Canada, including the Canadian Hypertension Society, the Canadian Hypertensive Education Program, public policies, community interventions, and healthcare systems. We summarize these advanced experiences in order to provide a policy-making basis for the development of hypertension prevention and control in China.
hypertension / awareness rate / control rate / treatment rate
| [1] |
McAlister F A, Wilkins K, Joffres M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades [J]. Canadian Medical Association Journal，2011,183(9): 1007–1013.
|
| [2] |
Robitaille C, Dai S, Waters C, et al. Diagnosed hypertension in Canada: Incidence, prevalence and associated mortality [J]. Cana-dian Medical Association Journal，2012, 184(1): 49–56.
|
| [3] |
Schiffrin E L, Campbell N R, Feldman R D, et al. Hypertension in Canada: Past, present, and future [J]. Annals of Global Health, 2016, 82(2): 288–299.
|
| [4] |
Chockalingam A, Campbell N, Ruddy T, et al. Canadian national high blood pressure prevention and control strategy [J].Canadian Journal of Cardiology, 2000 , 16(9): 1087–1093.
|
| [5] |
Chockalingam A, Abbott D, Bass M, et al. Recommendations of the Canadian consensus conference on nonpharmacological approaches to the management of high blood pressure [J]. Cannadian Medical Association Journal, 1990,142(12): 1397–1409.
|
| [6] |
Campbell N R, Brant R, Johansen H, et al. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada [J]. Hypertension, 2009, 53(2): 128–134.
|
| [7] |
Mcalister F A, Feldman R D, Wyard K, et al. The impact of the Canadian Hypertension Education Programme in its first decade[J]. European Heart Journal, 2009, 30(12): 1434–1439.
|
| [8] |
Campbell N R, Petrella R, Kaczorowski J. Public education on hypertension: A new initative to improve the prevention, treatment and control of hypertension in Canada[J]. Canadian Journal of Cardiology, 2006, 22(7): 599–603.
|
| [9] |
Sodium Working Group. Sodium reduction strategy for Canada: 121中国工程科学 2017 年 第 19 卷 第 2 期Recommendations of the sodium working group [R].
|
| [10] |
Kaczorowski J Chambers L W, Dolovich L, et al. Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP) [J]. British Medical Journal , 2011(342): d442.
|
| [11] |
Gutkin C. The future of family practice in Canada: The patient’s medical home [J]. Canadian Family Physician, 2011 , 57(10): 1224.
|
/
| 〈 |
|
〉 |
